Assembly Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $454.58 million, with shareholders equity totaling $198.61 million.
The company employs approximately 139 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Assembly Biosciences Inc. reported $71.10 million in revenue, generating net income of $-6.39 million.
Key financial metrics include a P/E ratio of -71.14, a price-to-book (P/B) ratio of 2.29, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ASMB.